Pacific Shuanglin Bio-pharmacy Co., Ltd.
SHZ: 000403.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xiankui Rong
- Employees
- 2,635
- Headquarters
- Taiyuan, China
- IPO year
- 2013
- Market cap
- CN¥11.1B
- Website
- https://www.slbiop.com
Loading 000403…
Loading profile data…Frequently asked questions about 000403
What does Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) do?
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human im...
Where does 000403.SZ trade?
Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) trades on the Shenzhen Stock Exchange.
What sector is 000403.SZ in?
Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Pacific Shuanglin Bio-pharmacy Co., Ltd.?
Xiankui Rong is the chief executive officer of Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ).
Where is Pacific Shuanglin Bio-pharmacy Co., Ltd. headquartered?
Pacific Shuanglin Bio-pharmacy Co., Ltd. is headquartered in China.
Does 000403.SZ pay a dividend?
Yes — Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) paid a trailing twelve-month dividend of CNY 0.27 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 000403.SZ go public?
Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) completed its initial public offering in 2013.